RXST
RxSight, Inc. · Healthcare · Medical - Devices
Input momentum (manajer yang sebanding):
keluasan pemegang -8.3% ·
aliran saham +15.3% ·
posisi baru bersih -9.1%
— formula
Akumulasi terkonsentrasi — peningkatan saham di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | -7 | 30.76M | $148.37M | +3 | −9 |
| Q1 2026 | 78 | +10 | 29.02M | $178.70M | +11 | −1 |
| Q4 2025 | 68 | 0 | 28.07M | $292.47M | +1 | −1 |
| Q3 2025 | 17 | 0 | 14.88M | $133.76M | +1 | −1 |
| Q2 2025 | 14 | 0 | 12.67M | $164.75M | +1 | −1 |
| Q1 2025 | 11 | -1 | 4.08M | $103.15M | — | −1 |
| Q4 2024 | 12 | 0 | 5.10M | $175.38M | — | — |
| Q3 2024 | 11 | -1 | 3.15M | $155.64M | — | −1 |
| Q2 2024 | 12 | — | 2.73M | $164.29M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasif) | 817.12K | +17.7% | $40.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasif) | 817.12K | +17.7% | $40.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Millennium Management ✦ | 567.47K | +200.9% | $28.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Point72 Asset Management ✦ | 446.98K | +610.2% | $22.09M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 419.00K | +17.0% | $20.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 419.00K | +17.0% | $20.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 419.00K | +17.0% | $20.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 419.00K | +17.0% | $20.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 282.22K | -17.5% | $13.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 211.74K | +66.1% | $10.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 211.74K | +66.1% | $10.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 178.20K | -22.6% | $8.81M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 102.39K | -62.7% | $5.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 61.20K | +4.4% | $3.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 61.20K | +4.4% | $3.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 40.05K | +7.6% | $1.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 40.05K | +7.6% | $1.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 22.25K | -29.8% | $1.10M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Marshall Wace | $19.51M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 162 pemegang, 37.72M saham, $223.80M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.